AP Photo/Ben Margot

Report: Dodgers to sign Japanese right-hander Kenta Maeda

17 Comments

UPDATE: Joel Sherman of the New York Post hears that Maeda’s deal with the Dodgers is for at least five years, but it’s “complicated” and includes a bunch of incentives.

6:24 p.m. ET: Yahoo Sports’ Jeff Passan reports that while the two sides have an agreement, details are still being worked out and the deal won’t be official for a few days.

5:41 p.m. ET: One day after adding left-hander Scott Kazmir to their rotation on a three-year contract, the Dodgers have signed Japanese right-hander Kenta Meada, according to Christopher Meola on Twitter. CBS Sports’ Jon Heyman has confirmed the report.

No word on the terms involved in the deal. In addition to a contract, the Dodgers will presumably pay the maximum $20 million posting fee to Maeda’s team in Japan, the Hiroshima Carp. Maeda was put through the posting process earlier this month and MLB teams faced a January 8th deadline to sign him to a contract. It comes as no surprise that he ended up with the Dodgers, as he reportedly paid a visit to Dodger Stadium a week ago.

Maeda turns 28 in April and posted a 2.39 ERA with 7.4 K/9 and 1.9 BB/9 over his eight seasons in Japan. He had a 2.09 ERA and 175/41 K/BB ratio in 206 1/3 innings this past season. While Maeda might not have the upside of other high-profile pitchers who have recently come over from Japan like Yu Darvish or Masahiro Tanaka, he should help a rotation which features multiple wild cards. He’ll also be the lone right-hander in a group which includes Clayton Kershaw, Kazmir, Brett Anderson, Alex Wood, and Hyun-Jin Ryu. Brandon McCarthy, another right-hander, is working his way back from Tommy John surgery and will likely be sidelined until around midseason.

Mike Trout to undergo foot surgery

Mike Trout
Getty Images
Leave a comment

Angels star outfielder Mike Trout is done for the year, per a team press release. He’ll undergo surgery to remove the Morton’s neuroma in his right foot sometime over the next week, which will likely require a recovery period that stretches beyond the two weeks remaining in the regular season.

Trout, 28, has been day-to-day with a foot injury since the first week of September. On Monday, he underwent a cryoablation procedure to treat the neuroma on his right foot, but evidently requires further treatment to resolve the issue completely. Per manager Brad Ausmus, Trout ‘tested his foot by running’ on Sunday and found he was still experiencing too much pain to play, prompting his decision to undergo season-ending surgery.

This figures to be the first major setback Trout has seen since his thumb surgery in 2017, but there’s no reason to believe his current ailment will have any substantial effect on his 2020 season. Still, it’s an unfortunate end to another monster campaign by the eight-time All-Star and AL MVP contender, who will finish his 2019 season batting .291/.438/.645 with an AL-best 45 home runs, .1083 OPS, and league-leading 8.6 fWAR.